Skip to main content

Coinfection of viruses in children with community-acquired pneumonia

Abstract

Background

Virus, particularly respiratory tract virus infection is likely to co-occur in children with community-acquired pneumonia (CAP). Study focusing on the association between common viruses coinfection and children with CAP is rare. We aimed to study the association between seven common viruses coinfection and clinical/laboratory indexes in children with CAP.

Methods

Six hundred and eighty-four CAP cases from our hospital were enrolled retrospectively. Seven common viruses, including influenza A (FluA), influenza B (FluB), human parainfluenza virus (HPIV), Esptein-Barr virus (EBV), coxsackie virus (CoxsV), cytomegalovirus (CMV), and herpes simplex virus (HSV) were investigated for their associations with CAP. We analyzed the differences of hospitalization days, white blood cell (WBC), c-reactive protein (CRP), platelet (PLT), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), urine red blood cell (uRBC), blood urea nitrogen (BUN), serum creatinine (Scr), alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK) and creatine kinase isoenzyme (CKMB) among different viruses coinfection groups by using one-way ANOVA analysis. The differences of clinical/laboratory indexes between ordinary and severe pneumonia groups, as well as non-virus vs multi co-infection viruses groups, and single vs multi co-infection viruses groups by using independent samples T test. Receiver operating characteristic (ROC) curve analyses were applied to test the the predictive value of the clinical/laboratory parameters for the risk of viruses coinfections among CAP. Binary logistic analysis was performed to test the association between various indexes and viruses co-infection.

Results

Eighty-four multiple viruses coinfections yielded different prognosis compared with that in 220 single virus coinfection. CMV coinfection was associated with longest hospitalization days, highest ALT, AST and CKMB level. HSV coinfection was associated with highest WBC count, CRP, ESR, and BUN. EBV coinfection was associated with highest PLT and PCT level. FluB coinfection was associated with highest Scr level. CoxsV coinfection was associated with highest uRBC, LDH and CK level. ROC curve analyses showed that CK had the largest area under the curve (AUC: 0.672, p < 10–4) for the risk of viruses coinfections risk in CAP. Significant association between PLT, uRBC, BUN, CK, and CKMB and virus coinfection risk in CAP was observed.

Conclusions

Multiple viruses coinfections indicated different prognosis. Different viruses coinfection yielded varying degrees of effects on the cardiac, liver, kidney and inflamatory injury in CAP. The alterations of clinical/laboratory parameters, particularly CK may be associated with the risk of viruses coinfections in CAP.

Peer Review reports

Introduction

Viruses infection is one of the most common health problems across the world [1]. CAP is likely to occur in the low immunity people, such as the aged and children in the cold season. Environmental pollution, crowd gathering, communication, and viruses coinfection may promote the onset of CAP, even leading to the injury of multi-organs. CAP accounts for the most common cause of death in children less than 5 years old [2]. On the other hand, many children are hospitalized due to CAP, particularly during the epidemic season, which leads to enormous social and economic burden. Hence, early prevention and treatment of CAP seems of great implications.

Streptococcus is the most common pathogen of CAP, appropriate antibiotic use yielded good therapeutic effects [3]. Mycoplasma pneumoniae is another common cause of atypical pneumonia presenting with its different course and extrapulmonary complications [4]. Azithromycin use shows good effects on mycoplasma pneumonia [5]. Active surveillance of these pathogens is helpful for the treatment of CAP. Notably, a number of CAP cases were refractory to conventional therapy, viruses coinfections may be an important cause, which affects the prognosis of CAP. Viruses are also the most commonly detected pathogens in children with CAP [6]. Respiratory syncytial virus (RSV) and rhinovirus were the most commonly detected causes in pediatric pneumonia [7]. RSV is likely to induce asthma-like symptoms, enterovirus is prone to lead to the onset of rash [8, 9]. On the other hand, the epidemic COVID-19 may also usually induce the lung injury, exacerbating the lung function [10]. Some severe CAP cases are even complicated with more than two viruses coinfections, leading to serious symptoms. Therefore, an in-depth understanding regarding the viruses coinfection during the course of CAP was of great significances.

Recently, etiological studies of children with CAP focused on the distribution of viruses in different ethnics, regions, populations and seasons. For example, RSV is commonly observed in the lower aged children [11]. Coinfections of multiple pathogens lead to more severe symptoms [12]. However, the specific association of CAP clinical/laboratory indexes with viruses coinfection was rare. We performed this retrospective study to analyse deeply the incidence, characteristics and differences of seven common viruses coinfections in children with CAP. We also determined the impact of seven common viruses coinfections on the clinical and laboratory parameters, including the hospitalisation days, inflammatory indexes, cardiac injury indexes, liver injury indexes, and kidney injury indexes. Additionally, receiver operating characteristic (ROC) curve analysis was used to calculate the predictive value of these parameters in the risk of certain viruses coinfections in CAP.

Methods

Study design

A retrospective investigation of seven common viruses coinfections in children with CAP was performed. This study was conducted to yield the impact of these viruses coinfections on the children with CAP. The study was approved by ethics committee of Shanghai Sixth People’s Hospital (Registration Clinical Trial Number. 2018–106). This study was performed according to the Declaration of Helsinki. As the study was performed in the retrospective style, the informed consent of guardians of participants was waived. All the included data was de-identified. We conducted the anonymous data analysis in the retrospective style.

Patient population

All the enrolled cases were the patients admitted to the Department of Pediatrics, Shanghai Sixth People’s Hospital, China. The age was between 1 and 14 years. The study period was between June 2016 and June 2018. The patients with systemic diseases that may affect the prognosis of CAP were excluded. All the recruited cases were inpatients.

Data collection

We extracted the clinical and laboratory parameters from the electronical medical records. We collected the data of age, gender, infected viruses and hospitalization days. In the meantime, we also collected the laboratory data, including white blood cell (WBC), c-reactive protein (CRP), platelet (PLT), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), urine red blood cell (uRBC),

blood urea nitrogen (BUN), serum creatinine (Scr), alanine aminotransferase (ALT), Aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK) and creatine kinase isoenzyme (CKMB). All the laboratory parameters were tested within three days after admission. CAP was divided into two types: ordinary pneumonia (OP) and severe pneumonia (SP). SP was defined as that multiple systems were injured besides the lung (presence of danger signs: persistent vomiting, lethargy or unconsciousness, seizures, severe malnutrition, stridor in a calm child or not able to drink) [13].

Virus detection

The panel for virus detection was done before the collection of specimens for biomarker analysis.

The nasopharyngeal swabs were collected for testing influenza A (FluA), influenza B (FluB), human parainfluenza virus (HPIV). Multiplex PCR assay was used for the detection of FluA, Flu B, and HPIV. The sensitivity of the multiplex PCR was evaluated by testing the limit of detection of the assay. The specificity of the multiplex PCR assay was evaluated by cross reaction tests with other common respiratory pathogens. We have no false positive results. Plasma samples were collected for testing Esptein-Barr virus (EBV), coxsackie virus (CoxsV), cytomegalovirus (CMV), and herpes simplex virus (HSV). ELISA method was used for the detection of IgM antibodies levels of EBV, CoxsV, CMV, and HSV. The samples were handled according to the manufacturer’s instructions. The tests were performed in the clinical laboratory of Shanghai Sixth People’s Hospital. Virus detection was performed after the collection of specimens. The results were defined as positive or negative with no quantitative analyses. The results were collected retrospectively.

Statistical analysis

Continuous variables were expressed as means ± standard deviation (SD), while categorical variables were expressed as percentages. Descriptive analyze were conducted to investigate the differences of these indexes among various viruses coinfection groups. Upset plot was used to show the distribution of multi viruses coinfections. One-way ANOVA analysis was applied to test the differences of these indexes among non-virus, single virus and multiple viruses coinfections groups. Independent samples T test was to determine the differences of these indexes between OP and SP groups, as well as non-virus vs multi co-infection viruses groups, and single vs multi co-infection viruses groups. ROC curve analysis was applied to test the predictive value of these parameters for the risk of virus coinfections among CAP. The Youden index is equal to sensitivity + 1-specificity. The corresponding point of Youden index is regarded as the optimal cut-off point. The ROC area > 0.50 with p value < 0.05 was regarded as the significant difference. Binary logistic analysis was performed to test the association between various indexes and viruses co-infection. All the quantitative analyses were performed by using SPSS version 19. P < 0.05 was considered statistically significant, except where otherwise specified.

Results

Incidence and distribution of virus

A total of 684 CAP cases were enrolled in our study. Among the recruited cases, 540 were OP, and 144 were SP. 380 cases were not infected with any virus, 220 cases were infected with single virus, and 84 cases were infected with at least two viruses. There are 42 FluA cases, 50 Flu B cases, 20 HPIV cases, 36 HSV cases, 108 EBV cases, 32 CMV cases, and 16 CoxsV cases (Table 1). Upset plot showed the distribution of multi viruses co-infections (Supplemental material 1).

Table 1 Baseline characteristics of enrolled participants

Descriptive analyses of various indexes among cases with viruses coinfections

CMV, EBV, and CoxsV coinfections were associated with the longest hospitalization days (9.00 ± 3.05, 7.87 ± 1.90, and 7.75 ± 2.46, respectively). HSV coinfection was associated with the shortest hospitalization days (5.50 ± 1.53). HSV, CMV, and HPIV coinfections were associated with the highest WBC count (15.93 ± 4.40, 12.80 ± 4.06, and 8.54 ± 3.97, respectively). FluA virus was associated with lowest WBC count (6.33 ± 2.95). HSV, CMV, and EBV coinfections were associated with the highest CRP level (63.67 ± 39.96, 48.35 ± 46.58, and 23.76 ± 36.55, respectively). FluB coinfection was associated with the lowest CRP level (8.64 ± 10.04). EBV, HSV and FluB coinfections were associated with the highest PLT level (283.11 ± 181.52, 275.33 ± 30.88, and 278.20 ± 125.98, respectively).

FluA coinfection was associated with the lowest PLT level (220.66 ± 52.61). HSV, FluA and EBV coinfections were associated with the highest ESR level (38.67 ± 22.01, 27.00 ± 10.81, and 22.30 ± 10.96, respectively). HPIV coinfection was associated with the lowest ESR level (12.80 ± 7.72).

EBV, HSV and FluA coinfections were associated with the highest PCT level (1.70 ± 5.06, 1.51 ± 1.32, and 0.57 ± 0.39, respectively). HPIV coinfection was associated with the lowest PCT level (0.08 ± 0.01). CoxsV, HSV and EBV coinfections were associated with the highest uRBC level (10.00 ± 5.89, 10.00 ± 4.38, and 8.72 ± 9.53, respectively). FluA coinfection was associated with the lowest uRBC level (2.00 ± 1.65). HSV, HPIV and CoxsV coinfections were associated with the highest BUN level (4.07 ± 0.17, 3.82 ± 0.89, and 3.57 ± 1.27, respectively). CMV coinfection was associated with the lowest BUN level (2.80 ± 0.20). FluB, FluA and HPIV coinfections were associated with the highest Scr level (33.80 ± 7.87, 30.00 ± 11.48, and 27.40 ± 4.57, respectively). CMV coinfection was associated with the lowest Scr level (16.00 ± 0.01). CMV, HSV and CoxsV coinfections were associated with the highest ALT level (229.00 ± 203.20, 38.33 ± 32.10, and 17.25 ± 9.39, respectively). HPIV infection was associated with the lowest ALT level (9.20 ± 1.36). CMV, HSV and CoxsV coinfections were associated with the highest AST level (206.50 ± 169.16, 34.33 ± 9.70, and 32.00 ± 2.63, respectively). HPIV coinfection was associated with the lowest AST level (24.20 ± 2.71). CoxsV, CMV and HSV coinfections were associated with the highest LDH level (401.00 ± 143.17, 353.00 ± 51.82, and 301.66 ± 30.64, respectively). FluA coinfection was associated with the lowest LDH level (242.33 ± 24.38). CoxsV, FluB and HSV coinfections were associated with the highest CK level (56.77 ± 16.07, 128.00 ± 76.02, and 93.67 ± 27.33, respectively). FluA coinfection was associated with the lowest CK level (59.67 ± 7.45). CMV, CoxsV and HSV coinfections were associated with the highest CKMB level (34.00 ± 5.08, 31.00 ± 1.48, and 28.33 ± 11.63, respectively). FluA coinfection was associated with the lowest CKMB level (15.00 ± 5.78) (Table 2, Supplemental material 2).

Table 2 Baseline characteristics of indexes among cases

Distribution of various viruses, and differences of various parameters among OP and SP

A total of 540 OP cases were enrolled. There were 74 EBV cases, 29 HSV cases, 16 HPIV cases, 36 FluA cases, 40 FluB cases, 22 CMV cases, and 12 CoxsV cases, respectively. A total of 144 SP cases were recruited. There were 34 EBV cases, 7 HSV cases, 4 HPIV cases, 6 FluA cases, 10 FluB cases, 10 CMV cases, and 4 CoxsV cases, respectively.

There were significant differences of days, WBC, CRP, PCT, uRBC, BUN, LDH, and CKMB between OP and SP. No marked differences of PLT, ESR, Scr, ALT, AST, and CK were noted between OP and SP (Table 3).

Table 3 Differences of various indexes between OP and SP

Differences of various parameters among non-virus, single virus and multiple viruses

Significant differences of days, WBC, CRP, PLT, ESR, PCT, uRBC, BUN, ALT, AST, LDH, CK, and CKMB among non-virus, single virus and multiple viruses were observed. No marked differences of Scr were noted among non-virus, single virus and multiple viruses (Table 4). Significant differences of WBC, CRP, PLT, ESR, BUN, LDH, CK, and CKMB between non-virus and multiple viruses were observed. No marked differences of days, PCT, uRBC, Scr, ALT, and AST were noted between non-virus and multiple viruses (Table 4). Significant differences of WBC, CRP, PLT, ALT, AST, and LDH were observed between single and multiple viruses were observed. No marked differences of days, PLT, ESR, PCT, uRBC, BUN, Scr, CK, and CKMB were noted between single and multiple viruses (Table 4).

Table 4 Differences of various indexes among non, single and multiviruses infections

ROC curve analysis of the predictive value of various indexes in virus coinfections of CAP

Significant association between the parameters of ALT, AST, LDH, CK, and CKMB and virus coinfection in CAP was observed. The optimal cut-off points and sensitivity and specificity for parameters mentioned above are shown in Table 5.

Table 5 Association between various indexes and virus infection

Binary logistic regression analysis of the association between various indexes and virus coinfections of CAP

Significant association between PLT, uRBC, BUN, CK, and CKMB and virus coinfection in CAP was observed (Table 5).

Discussion

Viruses coinfections are important facilitators of CAP susceptibility and progression [14]. Respiratory viruses are frequently detected in CAP among children. RSV, rhinovirus, and HMPV were the viruses most commonly detected in CAP. Moreover, many other viruses may also influence the development and progression of CAP. Notably, COVID-19 did not primarily manifest as CAP in immunocompetent children [15]. Hence, identification of the detailed role of other common viruses in children with CAP have important clinical implications.

Our study investigated the association between seven common viruses and children with CAP, which is of great implications for pediatric health. We found that multiple viruses coinfections resulted in different prognosis compared with those in non-virus and single virus coinfections. Different viruses coinfection yielded varying degrees of effects on the cardiac, liver, kidney and inflamatory injury in CAP. EBV coinfection was the most common virus detected in CAP. FluB and CMV were the second most common infected virus among OP and SP, respectively. Upset plot also indicated that EBV and FluB were the most common co-infected viruses. The status of clinical and laboratory parameters may be associated with viruses coinfections risk in CAP. Our findings were of great implications that specific clincial characteristics may indicate certain virus coinfection, monitoring of susceptible viruses in specific CAP cases will be helpful for the therapy of CAP in children, and different virus infection may be likely to be associated with different clinical presentations.

Several facts may explain our findings. First: EBV coinfection is likely occur early in life [16]. Many EBV coinfection cases are almost asymptomatic, meriting little attention, leading to the lower testing of EBV. Reactivation of EBV coinfection occurs in the low-immunity state [17], which accounted for the higher incidence of EBV coinfection in CAP. Although EBV is traditionally regarded as with no serious impact on the children, we found that EBV coinfection was associated higher level of PCT and PLT, which indicated that EBV coinfection may also affect the inflammatory state. FluB and CMV were the second most common infected virus among OP and SP, respectively. FluB virus is the common virus during the epidemic season [18]. FluB virus coinfection did not usually lead to serious problems, which explained the higher incidence of FluB virus coinfection in CAP. CMV coinfection was likely to lead to the refractory inflammation and liver injury, which explained that the higher incidence of CMV coinfection in SP [19]. On the other hand, we observed that CMV coinfection was associated with longest hospitalization days, highest ALT, AST and CKMB level, which indicated that CMV may lead to the poor prognosis, including the cardiac and liver injury. Monitoring of CMV coinfection may be needed among the the CAP cases with poor clinical presentations. We also noted that HSV coinfection was associated with highest WBC count, CRP level, ESR, and BUN levels, which suggested that HSV coinfection may aggravate the inflammatory state. HSV may affect the immune response, leading to the inflammation [20]. CoxsV coinfection was associated with highest uRBC, LDH and CK level, which indicated that CoxsV virus coinfection was closely associated with kidney and cardiac injury. Myocardial cells were prone to be injured by CoxsV coinfection [21].

Another important finding was that ROC curve analysis showed that CK had the largest ROC area under the curve for the risk of viruses coinfections in CAP. Binary logistic regression analysis also showed a significant association between CK and virus coinfection risk in CAP. Increased level of CK was closely associated with the viruses coninfection. This observation was of great implications that we should pay more attention to the possibility of viruses coinfection while the CK was increased markedly. Virus coinfections affect the inflammatory state, cardiac function, liver function, and kidney function, which may be due to that virus was likely to injure the tissues [22]. Therefore, monitoring of various parameters may be helpful for the prevention and therapy of virus coinfections.

Our study has important clinical implications that specific virus coinfection affects the progression of CAP. We also investigated some non-respiratory viruses, including EBV, CoxsV, CMV and HSV, which further deepen our knowledge regarding the association between CAP and various non-respiratory viruses. CK may be associated with the risk of viruses coinfection in CAP. We found that significant differences of parameters of cardiac injury, liver injury, kidney injury and inflammaton existed among different virus-coinfected populations. Hence, alteration of certain indexes may reflect the severity of certain coinfected virus, which is helpful for the effective early virus test. Meanwhile, several limitations should be considered in our study. First, the interaction between viruses and other pathogens may affect the prognosis of CAP. Comprehensive analysis of the interaction between viruses and other pathogens should be performed in the future. Second, further studies should be performed to clarify the detailed association between parameters and virus coinfection, such as the relatonship between alterations of biochemical indexes and viral load. Third, the immune status may affect the susceptibility to various viruses infections. Host genetic factors may play an important role in the outcome of respiratory tract infections. Previous study showed that two complement-related SNPs, rare TT genotype of CD55 and rare AA genotype of C1QBP, were associated with increased death risk of influenza, which indicated that mutations related to immunity may affect the prognosis [23]. We need to consider the host genetic factors while investigating the association between viruses infections and CAP in the future.

Finally, a prospective study design should be applied by excluding the confounding factors in the future. The data were extracted from June 2016 to June 2018 before the outbreak of COVID-19, we did not study the association between COVID-19 and CAP. Nevertheless, the detailed relationship between the seven common viruses coinfection and CAP merits in-depth investigation.

Based on our findings, future studies should be performed to address these two issues (1) elucidation of the detailed mechanisms of the interactions between viruses coinfections and other pathogens, (2) long-term and detailed follow-up of the alterations of various indexes and prognosis of various viruses coinfections with a favorable study design.

Conclusions

Our investigation indicated that viruses coinfections were common during the course of CAP.

Multiple viruses coinfections indicated different prognosis. Different viruses coinfection yielded varying degrees of effects on the cardiac, liver, kidney and inflamatory injury in CAP. CK may be associated with the risk of viruses coinfections in CAP.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

CAP:

Community-acquired pneumonia

FluA:

Influenza A

FluB:

Influenza B

HPIV:

Human parainfluenza virus

EBV:

Esptein-Barr virus

CoxsV:

Coxsackie virus

CMV:

Cytomegalovirus

HSV:

Herpes simplex virus

WBC:

White blood cell

CRP:

C-reactive protein

PLT:

Platelet

ESR:

Erythrocyte sedimentation rate

PCT:

Procalcitonin

uRBC:

Urine red blood cell

BUN:

Blood urea nitrogen

Scr:

Serum creatinine

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

LDH:

Lactate dehydrogenase

CK:

Creatine kinase

CKMB:

Creatine kinase isoenzyme

ROC:

Receiver operating characteristic

OP:

Ordinary pneumonia

SP:

Severe pneumonia

SD:

Standard deviation

References

  1. Niese R, van der Vlist D, Verhagen M, de Haan N, Stunnenberg M, Serafim F, Kretzschmar M, van der Wal A, Vermeulen L, Tholen A, de RodaHusman AM. Risk mapping of respiratory viral transmission and disease severity using individual and environmental health parameters: a scoping review and protocol analysis. One Health. 2024;18:100741.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Verma N, Awasthi S, Pandey AK, Gupta P. Association of Interleukin-1 Receptor Antagonist ( IL-1RA ) gene polymorphism with community-acquired pneumonia in north indian children: a case-control study. Glob Med Genet. 2023;10(2):109–16.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Green AE, Pottenger S, Monshi MS, Barton TE, Phelan M, Neill DR. Airway metabolic profiling during Streptococcus pneumoniae infection identifies branched chain amino acids as signatures of upper airway colonisation. PLoS Pathog. 2023;19(9):e1011630.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Jiang Z, Li S, Zhu C, Zhou R, Leung PHM. Mycoplasma pneumoniae Infections: pathogenesis and vaccine development. Pathogens. 2021;10(2):119.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wang H, Zhao M, Liu S, Wang X. Efficacy and safety of reduning injection combined with azithromycin in the treatment of mycoplasma pneumonia among children: a systematic review and meta-analysis. Phytomedicine. 2022;106:154402.

    Article  CAS  PubMed  Google Scholar 

  6. Yun KW, Wallihan R, Juergensen A, Mejias A, Ramilo O. Community-acquired pneumonia in children: myths and facts. Am J Perinatol. 2019;36(S 02):S54–7.

    Article  PubMed  Google Scholar 

  7. Pratt MTG, Abdalla T, Richmond PC, Moore HC, Snelling TL, Blyth CC, Bhuiyan MU. Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(8):555–70.

    Article  PubMed  Google Scholar 

  8. Baraldi E, Bonadies L, Manzoni P. Evidence on the link between respiratory syncytial virus infection in early life and chronic obstructive lung diseases. Am J Perinatol. 2020;37(S 02):S26–30.

    Article  PubMed  Google Scholar 

  9. Zhang M, Wang H, Tang J, He Y, Xiong T, Li W, Qu Y, Mu D. Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021;21(1):127.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hashemian SM, Farhadi T, Varahram M, Velayati AA. Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury. Expert Rev Anti Infect Ther. 2023;21(1):7–14.

    Article  CAS  PubMed  Google Scholar 

  11. Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S. RSV prevention in all infants: which is the most preferable strategy? Front Immunol. 2022;13:880368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chen J, Zhao Y, Shang Y, Lin Z, Xu G, Bai B, Zheng J, Li P, Mao Y, Deng Q, Yu Z. The clinical significance of simultaneous detection of pathogens from bronchoalveolar lavage fluid and blood samples by metagenomic next-generation sequencing in patients with severe pneumonia. J Med Microbiol. 2021;70:001259:1-8.

  13. Scott JA, Wonodi C, Moïsi JC, Deloria-Knoll M, DeLuca AN, Karron RA, Bhat N, Murdoch DR, Crawley J, Levine OS, O’Brien KL, Feikin DR. The definition of pneumonia, the assessment of severity, and clinical standardization in the pneumonia etiology research for child health study. Clin Infect Dis. 2012;2:S109–16.

    Article  Google Scholar 

  14. Smith DK, Kuckel DP, Recidoro AM. Community-acquired pneumonia in children: rapid evidence review. Am Fam Physician. 2021;104(6):618–25.

    PubMed  Google Scholar 

  15. Dulek DE, Ardura MI, Green M, Michaels MG, Chaudhuri A, Vasquez L, Danziger-Isakov L, Posfay-Barbe KM, McCulloch MI, L’Huillier AG, Benden C. Update on COVID-19 vaccination in pediatric solid organ transplant recipients. Pediatr Transplant. 2022;26(5):e14235.

    Article  CAS  PubMed  Google Scholar 

  16. Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787–821.

    Article  CAS  PubMed  Google Scholar 

  17. Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72(10):651–8.

    Article  CAS  PubMed  Google Scholar 

  18. Zhu G, Xu D, Zhang Y, Wang T, Zhang L, Gu W, Shen M. Epidemiological characteristics of four common respiratory viral infections in children. Virol J. 2021;18(1):10.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Komura T, Kagaya T, Takayama H, Yanagi M, Yoshio T, Sugimoto S, Nishino M, Orita N, Asahina Y, Nishikawa M, Kaneko S, Unoura M. Clinical features and dynamics of T cells-related markers in immunocompetent patients with cytomegalovirus hepatitis. Can J Gastroenterol Hepatol. 2020;2020:8874620.

    Article  PubMed  PubMed Central  Google Scholar 

  20. He L, Wang B, Li Y, Zhu L, Li P, Zou F, Bin L. The solute carrier transporter SLC15A3 participates in antiviral innate immune responses against herpes simplex virus-1. J Immunol Res. 2018;2018:5214187.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wang Y, Zhuan X, Peng Y, Li Q, Huang C, Huang H, Liang Z, Wang Q, Chang J. In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3. Acta Virol. 2021;65(1):58–67.

    Article  PubMed  Google Scholar 

  22. Hu Z, Hu J, Hu S, Song Q, Ding P, Zhu J, Liu X, Wang X, Liu X. High levels of virus replication and an intense inflammatory response contribute to the severe pathology in lymphoid tissues caused by Newcastle disease virus genotype VIId. Arch Virol. 2015;160:639–48.

    Article  CAS  PubMed  Google Scholar 

  23. Chatzopoulou F, Gioula G, Kioumis I, Chatzidimitriou D, Exindari M. Identification of complement-related host genetic risk factors associated with influenza A(H1N1) pdm09 outcome: challenges ahead. Med Microbiol Immunol. 2019;208(5):631–40.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would express our thanks to the data collectors for their cooperation.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

Song Mao and Liangxia Wu wrote the main manuscript text and Song Mao prepared Tables 1-4 and supplemental material. All authors reviewed the manuscript.

Corresponding author

Correspondence to Song Mao.

Ethics declarations

Ethics approval and consent to participate

The study was approved by ethics committee of Shanghai Sixth People’s Hospital (No. 2018–106).

The ethics approval (No. 2018–106, provided in supplemental material) form in both Chinese and English stated the waiver for the requirement of informed consent. The study was conducted in accordance with the Declaration of Helsinki. The study complied with all regulations. This investigation was performed in the retrospective style. All the enrolled data was de-identified. We performed the anonymous data analysis in the retrospective style.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mao, S., Wu, L. Coinfection of viruses in children with community-acquired pneumonia. BMC Pediatr 24, 457 (2024). https://doi.org/10.1186/s12887-024-04939-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-024-04939-0

Keywords